Personal information

Countries

China

Activities

Collapse all

Works (11)

CD36-mediated accumulation of MDSCs exerts abscopal immunosuppressive responses in hepatocellular carcinoma after insufficient microwave ablation

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
2024-12 | Journal article
DOI: 10.1016/j.bbadis.2024.167493
Contributors: Qing-Qing Liu; Hui-Zhou Li; Shu-Xian Li; Yan Bao; Tian-Cheng Wang; Chao Hu; Yu-Dong Xiao
Source: check_circle
Crossref

Combined Bone Mineral Density (BMD) and Monocyte-to-Lymphocyte Ratio (MLR) Predicts Recurrence and Prognosis in Hepatocellular Carcinoma Patients Following Liver Resection

Risk Management and Healthcare Policy
2024-11 | Journal article
DOI: 10.2147/RMHP.S473247
Contributors: Ze-Jiao He; Tao Hu; Zi-Shu Zhang; Tian-Cheng Wang; Wei Huang
Source: check_circle
Crossref

Subcutaneous adipose tissue/neutrophil-to-lymphocyte ratio is a potential biomarker in patients with hepatocellular carcinoma undergoing liver resection

Science Progress
2024-10 | Journal article
DOI: 10.1177/00368504241304195
Contributors: Shu-Xian Li; Yan Bao; Tian-Cheng Wang
Source: check_circle
Crossref

Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection

Journal of Hepatocellular Carcinoma
2023-11 | Journal article
DOI: 10.2147/JHC.S440636
Contributors: Hong-Mei Li; Wei Huang; Chao Hu; Zi-Shu Zhang; Yu-Dong Xiao; Tian-Cheng Wang
Source: check_circle
Crossref

Preoperative Systemic Immune-Inflammation Index is a Potential Biomarker in Adult Patients with High-Grade Gliomas Undergoing Radical Resection

Journal of Inflammation Research
2023-08 | Journal article
DOI: 10.2147/JIR.S423488
Contributors: Yu-Ting Jiang; Tian-Cheng Wang; Wei Zhang
Source: check_circle
Crossref

DDX24 promotes metastasis by regulating RPL5 in non‐small cell lung cancer

Cancer Medicine
2022-12 | Journal article
DOI: 10.1002/cam4.4835
Contributors: Xinyan Hu; Fangfang Li; Yulan Zhou; Hairun Gan; Tiancheng Wang; Luting Li; Haoyu Long; Bing Li; Pengfei Pang
Source: check_circle
Crossref

Inflammation-Regulated Nanodrug Sensitizes Hepatocellular Carcinoma to Checkpoint Blockade Therapy by Reprogramming the Tumor Microenvironment

ACS Applied Materials & Interfaces
2022-11-09 | Journal article
DOI: 10.1021/acsami.2c14448
Contributors: TianCheng Wang; MinZhao Lin; JunJie Mao; LiRong Tian; HaiRun Gan; XinYan Hu; LeYe Yan; HaoYu Long; JianXun Cai; XiaoDi Zheng et al.
Source: check_circle
Crossref

Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial

Journal of Hepatocellular Carcinoma
2021-10 | Journal article
DOI: 10.2147/JHC.S331779
Contributors: Li-Zhou Wang; Xiao-Xia Hu; Xiang-Chun Shen; Tian-Cheng Wang; Shi Zhou
Source: check_circle
Crossref

Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE

Risk Management and Healthcare Policy
2021-06 | Journal article
DOI: 10.2147/RMHP.S316740
Contributors: Tian-Cheng Wang; Tian-Zhi An; Jun-Xiang Li; Peng-Fei Pang
Source: check_circle
Crossref

Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.

Frontiers in molecular biosciences
2021-03-18 | Journal article
DOI: 10.3389/fmolb.2021.633590
PMID: 33816555
PMC: PMC8012485
Source: Self-asserted source
Tian-Cheng Wang

Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma.

Journal of pain research
2020-03-27 | Journal article
DOI: 10.2147/jpr.s246197
PMID: 32273750
PMC: PMC7108874
Source: Self-asserted source
Tian-Cheng Wang
How many people are using ORCID?